Nutritional needs are ‘shifting’ amid rise of weight loss drugs, says Nestle CEO
The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, Nestle CEO Mark Schneider told CNBC. Investors were initially concerned about the popularity of GLP-1 drugs such as Wegovy and Ozempic as it was assumed […]
Health
